frequently-asked-questions

BHG CMO Announcement | Opioid Addiction Treatment Services

Behavioral Health Group Announces Appointment of Kelly Clark, MD, MBA as Chief Medical Officer

DALLAS, TX, July 25, 2012 /PRNewswire/ — The Board of Directors of Behavioral Health Group (“BHG” or “the Company”) today announced the appointment of Kelly J. Clark, MD, MBA, as Chief Medical Officer. Dr. Clark joined BHG July 9, 2012.

 

Dr. Clark joins BHG with a wide breadth and depth of both clinical and administrative experience. She has practiced addiction medicine and psychiatry throughout the continuum of care, and taught addiction treatment as a faculty member of the University of Massachusetts. She comes to BHG having most recently worked to integrate medical and behavioral health care management as Medical Director at CDPHP. She serves as President of the Kentucky Society of Addiction Medicine, where she has practiced medicine for several years and served as Medical Director of a number of Opioid Treatment Programs.

 

“I am thrilled to join BHG in the work of providing excellent treatment services to those patients suffering under the epidemic of opioid addiction,” said Clark. “This disease is ravaging individual lives and entire communities across the country. BHG is uniquely situated to bring best practice medication assisted treatment to thousands of patients, and I am excited to work to increase access to evidence-based, physician-directed, team-delivered, high-quality care”.

 

A Phi Beta Kappa graduate of Coe College in Cedar Rapids, Iowa, Kelly holds a Doctor of Medicine degree from the University of Wisconsin, and a Master of Business Administration with Additional Certification in Health Sector Management from the Fuqua School of Business at Duke University. She is currently on the faculty of the Virginia Tech Carillion School of Medicine. Dr. Clark is a Fellow of the American Society of Addiction Medicine, where she serves as a Director, and is a Distinguished Fellow of the American Psychiatric Association.

 

BHG’s Chairman and CEO, Michael N. Cannizzaro, said of the appointment: “The Board is delighted to welcome Kelly to BHG’s executive team as Chief Medical Officer. Her talents and experiences will be invaluable in directing the pharmacotherapy and behavioral therapy aspect of our business as she builds the Medical Directorate of our company.”

 

About Behavioral Health Group

 

Behavioral Health Group (BHG) is a leading provider of opioid addiction treatment services. BHG utilizes pharmacotherapy (maintenance and detoxification) and behavioral therapy (counseling) to treat both the bio-chemical and psycho-social aspects of addiction. In doing so, BHG offers its patients their best shot at successful recovery. With 23 outpatient treatment centers across the midwest/south/southeast, BHG provides a critical service to thousands of individuals and their communities across the country. BHG’s treatment centers are accredited by The Joint Commission.

 

For more information, call (214) 365-6100, email inquiries@bhgrecovery.com, or visit http://www.bhgrecovery.com.

 

Behavioral Health Group Contact: James F. Draudt, COO

Frequently Asked Questions:

Q
A

Q: Shouldn’t people be able to “just quit?”

It is extremely difficult to overcome a drug addiction. Many have tried to “just quit,” but unfortunately, typically fail. Because of the physical effects of prolonged drug usage, the body has become chemically dependent on the very thing it should avoid. We have consistently found, and independent research proves, that by combining medication-assisted treatment with […]

MORE

Words From Our Patients:

Methadone treatment, for me, has been a blessing. If I had not been accepted into methadone treatment, my life would be in complete chaos. I truly believe because of this treatment, I am alive, have great relations with my family, have God in my life, and also have a beautiful son. More people need to […]

MORE